Sibutramine: Myths and Realities

Abstract

The paper presents data from competent drug controlling agencies form Russia, United States, Europe and other regions, comments on the main serious misconceptions of sibutramine-containing medicines, discusses the prerequisites for the analysis of the situation with sibutramine that initiated a SCOUT study, analyzes the history of sibutramine-containing drug Meridia. The results of observational research programs carried out in Russia (completed – "VESNA" and continued – "Primavera") are discussed in relation to the efficacy and safety of sibutramine-containing drug Reduxine for the target audience patients.